Limited inclusion of Latin American individuals in genomic studies
Some progress in PTSD, SCZ, BD, and MDD
Dominance of US-Based cohorts
Urgent need for focused research in Latin America
|
Consortia-building efforts, community-engaged research and funding sources
Engage local consortia, such as the LAGC, to facilitate genomic studies
Establish partnerships with patients, families, and advocates, via community based participatory research (CBPR) or Patient Advisory Boards (PAB)
Engage local researchers and provide genotyping/sequencing support
Public and private funding to support local research efforts
|
|
Lack of diversity in the researcher workforce
|
Training and career development programs
Train early-career stage LMIC researchers in advanced analysis
Provide funding opportunities
Develop training programs that avoid brain drain from the area
|
Biocolonialism and mistrust
LMIC researchers may be asked to provide data without significant involvement
Unequal benefit sharing as discoveries may benefit only high-income countries
Neglected translation of scientific output
|
Capacity building and equitable and sustainable collaborations
Resources to conduct studies locally
Local workshops to provide specialized training
Funding support for infrastructure
|
Lack of methodology and reference panels to account for complex admixture
Latin Americans have a heterogeneous ancestral composition
This complexity often leads to their exclusion due to concerns of population stratification
Fine-mapping more challenging due to heterogeneity in LD and effect sizes
|
Novel methods and reference panels
Methods must take admixture into account
Expanded reference panels for indigenous populations with ethical and local partnerships
New statistical fine-mapping methods are needed
|
|
Heterogeneity of outcomes and diagnosis assessment
|
Appropriate and standardized assessments
|